Shetzline M - Search Results

1

An open-label phase 1 clinical trial of the anti-α₄β₇ monoclonal antibody vedolizumab in HIV-infected individuals.

Sneller MC, Clarridge KE, Seamon C, Shi V, Zorawski MD, Justement JS, Blazkova J, Huiting ED, Proschan MA, Mora JR, Shetzline M, Moir S, Lane HC, Chun TW, Fauci AS. Sneller MC, et al. Among authors: shetzline m. Sci Transl Med. 2019 Sep 11;11(509):eaax3447. doi: 10.1126/scitranslmed.aax3447. Epub 2019 Sep 5. Sci Transl Med. 2019. PMID: 31488581 Clinical Trial.

2

Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.

Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA. Chey WD, et al. Among authors: shetzline ma. Am J Gastroenterol. 2008 May;103(5):1217-25. doi: 10.1111/j.1572-0241.2008.01808.x. Am J Gastroenterol. 2008. PMID: 18477346 Free article. Clinical Trial.

3

Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis.

Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M. Suh DC, et al. Among authors: shetzline m. Aliment Pharmacol Ther. 2007 Mar 15;25(6):681-92. doi: 10.1111/j.1365-2036.2007.03250.x. Aliment Pharmacol Ther. 2007. PMID: 17311601 Free article.

4

Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation.

Müller-Lissner S, Kamm MA, Musoglu A, Earnest DL, Dunger-Baldauf C, Shetzline MA. Müller-Lissner S, et al. Among authors: shetzline ma. Am J Gastroenterol. 2006 Nov;101(11):2558-69; quiz 2671. doi: 10.1111/j.1572-0241.2006.00789.x. Am J Gastroenterol. 2006. PMID: 17090282 Clinical Trial.

5

Neurohumoral control of the exocrine pancreas.

Shetzline MA, Liddle RA. Shetzline MA, et al. Curr Opin Gastroenterol. 1999 Sep;15(5):380-4. doi: 10.1097/00001574-199909000-00002. Curr Opin Gastroenterol. 1999. PMID: 17023977

6

Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.

Rodriguez-Stanley S, Zubaidi S, Proskin HM, Kralstein JR, Shetzline MA, Miner PB Jr. Rodriguez-Stanley S, et al. Among authors: shetzline ma. Clin Gastroenterol Hepatol. 2006 Apr;4(4):442-50. doi: 10.1016/j.cgh.2006.01.014. Clin Gastroenterol Hepatol. 2006. PMID: 16616348 Clinical Trial.

7

Factors motivating dyspepsia patients to enter clinical research.

Rojavin MA, Downs P, Shetzline MA, Chilingerian R, Cohard-Radice M. Rojavin MA, et al. Among authors: shetzline ma. Contemp Clin Trials. 2006 Apr;27(2):103-11. doi: 10.1016/j.cct.2005.11.014. Epub 2006 Jan 18. Contemp Clin Trials. 2006. PMID: 16413229

8

Ischemic colitis, irritable bowel syndrome, and tegaserod--an alternative viewpoint.

Shetzline MA, Cohard-Radice M, Joelsson B. Shetzline MA, et al. Pharmacotherapy. 2005 Nov;25(11):1684-5; discussion 1685. doi: 10.1592/phco.2005.25.11.1684. Pharmacotherapy. 2005. PMID: 16232032 No abstract available.

9

Capsule endoscopy structured terminology (CEST): proposal of a standardized and structured terminology for reporting capsule endoscopy procedures.

Korman LY, Delvaux M, Gay G, Hagenmuller F, Keuchel M, Friedman S, Weinstein M, Shetzline M, Cave D, de Franchis R. Korman LY, et al. Among authors: shetzline m. Endoscopy. 2005 Oct;37(10):951-9. doi: 10.1055/s-2005-870329. Endoscopy. 2005. PMID: 16189767 Review. No abstract available.

10

Direct percutaneous endoscopic jejunal feeding tube placement.

Shetzline MA, Suhocki PV, Agrawal N. Shetzline MA, et al. Am J Gastroenterol. 2005 Jul;100(7):1627-8; author reply 1628. doi: 10.1111/j.1572-0241.2005.50006_11.x. Am J Gastroenterol. 2005. PMID: 15985001 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page